200214-48-8

Basic information

• Product Name: tert-butyl N-[4-chloro-3-(hydroxymethyl)phenyl]carbamate
• Synonyms: tert-butyl N-[4-chloro-3-(hydroxymethyl)phenyl]carbamate
• CAS NO: 200214-48-8
• Molecular Weight: 257.717
• Mol File: 200214-48-8.mol
• Article Data: 5

Chemical Properties

• Boiling Point: 334.2±37.0 °C(Predicted)
• Density: 1.261±0.06 g/cm3(Predicted)
• CAS DataBase Reference: tert-butyl N-[4-chloro-3-(hydroxymethyl)phenyl]carbamate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl N-[4-chloro-3-(hydroxymethyl)phenyl]carbamate(200214-48-8)
• EPA Substance Registry System: tert-butyl N-[4-chloro-3-(hydroxymethyl)phenyl]carbamate(200214-48-8)

Safety Data

• Hazardous Substances Data: 200214-48-8(Hazardous Substances Data)

Upstream product

• 24424-99-5 di-tert-butyl dicarbonate 
• 89951-56-4 4-chloro-5-hydroxymethyl aniline 
• 89-54-3 2-chloro-5-aminobenzoic acid 
• 543-27-1 isobutyl chloroformate 
• 6361-21-3 2-chloro-5-nitrobenzaldehyde 
• 64401-55-4 5-amino-2-chloro-benzoic acid ethyl ester 
• 80866-80-4 2-chloro-5-nitrobenzyl alcohol 

Downstream Products

• 1228658-06-7 tert-butyl (4-chloro-3-formylphenyl)carbamate 
• 1341693-01-3 4-chloro-3-[(cyclopentylsulfanyl)methyl]aniline 
• 1569737-05-8 N-{4-chloro-3-[(cyclopentylsulfanyl)methyl]phenyl}thiophene-2-carboximidamide 
• 1569737-95-6 tert-butyl N-[4-chloro-3-[(cyclopentylsulfanyl)methyl]phenyl]carbamate 
• 1251929-41-5 tert-butyl N-[3-(bromomethyl)-4-chlorophenyl]carbamate 
• 934477-05-1 C₂₂H₃₀ClN₃O₇S 
• 934477-04-0 2-(5-tert-butoxycarbonylamino-2-chloro-phenyl)-acrylic acid ethyl ester 
• 200214-52-4 ethyl (2-chloro-5-(Boc-amino)phenyl)acetate 
• 200214-50-2 (2-chloro-5-(Boc-amino)phenyl)acetonitrile 
• 409082-02-6 ethyl 2-(5-amino-2-chlorophenyl)acetate 
• 200214-49-9 2-chloro-5-(Boc-amino)benzyl mesylate 

Relevant articles and documents

New hits as antagonists of GPR103 identified by HTS

Preclinical data indicate that GPR103 receptor and its endogenous neuropeptides QRFP26 and QRFP43 are involved in appetite regulation. A high throughput screening (HTS) for small molecule GPR103 antagonists was performed with the clinical goal to target weight management by modulation of appetite. A high hit rate from the HTS and initial low confirmation with respect to functional versus affinity data challenged us to revise the established screening cascade. To secure high quality data while increasing throughput, the binding assay was optimized on quality to run at single concentration. This strategy enabled evaluation of a larger fraction of chemical clusters and singletons delivering 17 new compound classes for GPR103 antagonism. Representative compounds from three clusters are presented. One of the identified clusters was further investigated, and an initial structure-activity relationship study is reported. The most potent compound identified had a pIC50 of 7.9 with an improved ligand lipophilic efficiency.

(PYRAZOL-3-YL)-1,3,4-THIADIAZOL-2-AMINE AND (PYRAZOL-3-YL)-1,3,4-THIAZOL-2-AMINE COMPOUNDS

A compound of Formula (I) wherein: either X is N and Y is CR5 or X is C and Y is S; Z is selected from N and CH; R1 is selected from H and Me; R2 is selected from H, OH, OMe and Me; each R3 is independently selected from C1-3alkyl, F, Cl, Br, CF3 and NH2; R4 is selected from Me, CF3, NO2 and CHF2; R5 is selected from H, Me and CHF2; R6 is selected from H and Me; and p is 0-3, compositions containing them, their use in therapy, for example in the treatment of tuberculosis, and methods for the preparation of such compounds, are provided.

AMINO ACID DERIVATIVES AND THEIR USE AS THROMBIN INHIBITORS

There is provided compounds of formula I, wherein R 1, R 2, R 3, R x, Y, n and B have meanings given in the description which are useful as competitive inhibitors of trypsin-like proteases, such as thrombin, and in particular in the treatment of conditions where inhibition of thrombin is required as in thrombosis or as anticoagulants.